Scan to Download
One power score. Smarter investment decisions
Bicara Therapeutics Inc
BCAX11.060USD
+0.090+0.82%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
0.000USD0.000Pre-market 09/19, 09:30 (ET)
603.39MMarket Cap
LossP/E TTM
Bicara Therapeutics Inc
11.060
+0.090+0.82%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q1
FY2023Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---25.59M
-92.68%-28.11M
---30.03M
-63.54%-17.22M
---14.59M
---10.53M
Net income from continuing operations
---27.39M
-194.58%-36.85M
---20.96M
23.48%-17.48M
---12.51M
---22.84M
Operating gains losses
--19.00K
46.15%19.00K
--15.00K
650.00%15.00K
--13.00K
--2.00K
Other non-cash items
--211.00K
112.31%138.00K
---276.00K
161.54%68.00K
--65.00K
--26.00K
Change in working capital
---1.93M
255.33%5.13M
---11.99M
-18.89%-1.86M
---3.30M
---1.56M
-Change in prepaid expenses
--627.00K
1851.49%4.12M
---16.57M
-532.00%-108.00K
---235.00K
--25.00K
-Change in payables and accrued expense
---2.38M
138.75%1.16M
--4.28M
-6.14%-1.68M
---3.00M
---1.58M
Cash from non-recurring investing activities
Cash from operating activities
---25.59M
-92.68%-28.11M
---30.03M
-63.54%-17.22M
---14.59M
---10.53M
Investing cash flow
Net cash from continuing investing activities
--0.00
100.00%0.00
--40.00K
-94.67%8.00K
---58.00K
--150.00K
Capital expenditures
--0.00
-100.00%0.00
--40.00K
-94.67%8.00K
--4.00K
--150.00K
Net cash flow from disposal of fixed assets
--0.00
100.00%0.00
--40.00K
-94.67%8.00K
---58.00K
--150.00K
Cash from non-current investing activities
Net cash flow from investing activities
--0.00
-100.00%0.00
---40.00K
94.67%-8.00K
--58.00K
---150.00K
Financing cash flow
Cash flow from continuous financing activities
--135.00K
235.77%460.00K
---975.00K
737.39%334.13M
--137.00K
--39.90M
Net cash flow from common stock issuance/repurchase
----
----
---1.05M
--333.48M
----
----
Proceeds from stock option exercised by employees
--135.00K
235.77%460.00K
--77.00K
-28.57%60.00K
--137.00K
--84.00K
Net cash flow from other financing activities
----
----
----
--596.00K
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
--135.00K
235.77%460.00K
---975.00K
737.39%334.13M
--137.00K
--39.90M
Net cash flow
Beginning cash balance
--462.06M
112.51%489.71M
--520.76M
1259.94%203.85M
--230.44M
--14.99M
Current period cash flow changes
---25.46M
-92.09%-27.65M
---31.05M
984.54%316.90M
---14.39M
--29.22M
Ending cash balance
--436.61M
113.87%462.06M
--489.71M
1077.92%520.76M
--216.05M
--44.21M
Free cash flow
---25.59M
-92.63%-28.11M
---30.07M
-61.32%-17.23M
---14.59M
---10.68M
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
